Green Tea 600 60 C

Green Tea 600 60 C by Xymogen

Green Tea 600 by Xymogen is an ultra-pure, water-extracted green tea formula.* It contains a plethora of ingredients that support anti-oxidation.* If you seek a natural anti-oxidant from a reliable source, Xymogen’s Green Tea 600 might be the right choice for you.*

Who Should Consider Green Tea 600 60 C?

Green Tea 600 60 C by Xymogen may support your health if you:

• often catch colds or infections*
• seek a natural anti-oxidant supplement*
• prefer a concise supplement over drinking multiple cups of green tea daily*

Green Tea 600 60 C by Xymogen—Effects

Xymogen’s Green Tea 600 60 C may:

• support antioxidation*
• support immune function*
• promote healthy endocrine function*

Supplements support your health but do not replace a balanced diet. Always check with your healthcare practitioner if you have doubts about a new supplement. Book a FREE product consultation to learn more about this product.

Recommendation: Xymogen suggests taking one Green Tea 600 capsule daily, or as directed by your healthcare professional.

Consult your healthcare professional prior to use. Individuals taking medication should discuss potential interactions with their healthcare professional. Do not use if tamper seal is damaged.

Serving Size: 1 Capsule
Servings Per Container: 60

Amount Per Serving:
Green Tea Aqueous Extract (Camellia sinensis)(leaf)(60% Catechins, 30% EGCG, 6% Caffeine) 600 mg

Other Ingredients: HPMC (capsule), stearic acid, magnesium stearate, and silica.

Does Not Contain: Wheat, gluten, corn, yeast, soy, animal and dairy products, fish, shellfish, peanuts, tree nuts, egg, ingredients derived from genetically modified organisms (GMOs), artificial colors, artificial sweeteners, and artificial preservatives.

Storage: Keep closed in a cool, dry place out of reach of children.

* The statements have not been evaluated by the Food and Drug Administration.

Products listed are not intended to diagnose, treat, cure, or prevent disease.

© 2013 2014 XYMOGEN®

Click here to view Data Sheet

LEGAL NOTICE: Xymogen's Exclusive Professional Formulas are available through select licensed health care professionals. The Internet Sale and Discounting of XYMOGEN formulas are strictly prohibited. covenanthealthproducts.com makes XYMOGEN formulas available only to patients of our clinic. If you are a patient of covenanthealthproducts.com, you may inquire about XYMOGEN by calling (800) 627-6518

*These statements have not been evaluated by the FDA. This product is not intended to diagnose, treat, cure, or prevent any disease.

References:

1. Weisburger, J. H., & Chung, F. L. (2002). Mechanisms of chronic disease causation by nutritional factors and tobacco products and their prevention by tea polyphenols. Food and Chemical Toxicology, 40(8), 1145–1154. https://doi.org/10.1016/S0278-6915(02)00051-5
2. Matsunaga, K., Klien, T. W., Friedman, H., & Yamamoto, Y. (2001). Legionella pneumophila replication in macrophages inhibited by selective immunomodulatory effects on cytokine formation by epigallocatechin gallate, a major form of tea catechins. Infection and Immunity, 69(6), 3947–3953. https://doi.org/10.1128/IAI.69.6.3947-3953.2001
3. Dulloo, A. G., Duret, C., Rohrer, D., Girardier, L., Mensi, N., Fathi, M., Chantre, P., & Vandermander, J. (1999). Efficacy of a green tea extract rich in catechin polyphenols and caffeine in increasing 24-h energy expenditure and fat oxidation in humans. The American Journal of Clinical Nutrition, 70(6), 1040–1045. https://doi.org/10.1093/ajcn/70.6.1040
4. Kao, Y. H., Hiipakka, R. A., & Liao, S. (2000). Modulation of endocrine systems and food intake by green tea epigallocatechin gallate. Endocrinology, 141(3), 980–987. https://doi.org/10.1210/endo.141.3.7406
5. Wheeler, D. S., Catravas, J. D., Odoms, K., Denenberg, A., & Wong, H. R. (2004). Epigallocatechin-3-gallate, a green tea-derived polyphenol, inhibits IL-1 beta-dependent proinflammatory signal transduction in cultured respiratory epithelial cells. The Journal of Nutrition, 134(5), 1039–1044. https://doi.org/10.1093/jn/134.5.1039
6. Dudka, J., Jodynis-Liebert, J., Korobowicz, E., Burdan, F., Szumilo, J., & Jasiecki, J. (2005). Activity of NADPH-cytochrome P-450 reductase of the human heart, liver, and lungs in the presence of (-)-epigallocatechin gallate, quercetin, and resveratrol: An in vitro study. Basic & Clinical Pharmacology & Toxicology, 97(2), 74–79. https://doi.org/10.1111/j.1742-7843.2005.pto_179.x
7. Townsend, P. A., Scarabelli, T. M., Pasini, E., Gitti, G., Menegazzi, M., Suzuki, H., … & Stephanou, A. (2004). Epigallocatechin-3-gallate inhibits STAT-1 activation and protects cardiac myocytes from ischemia/reperfusion-induced apoptosis. FASEB Journal, 18(13), 1621–1623. https://doi.org/10.1096/fj.04-1550fje
8. Rizvi, S. I., Zaid, M. A., Anis, R., & Mishra, N. (2005). Protective role of tea catechins against oxidation-induced damage of type 2 diabetic erythrocytes. Clinical and Experimental Pharmacology & Physiology, 32(1-2), 70–75. https://doi.org/10.1111/j.1440-1681.2005.04146.x
9. Anderson, R. A., & Polansky, M. M. (2002). Tea enhances insulin activity. Journal of Agricultural and Food Chemistry, 50(24), 7182–7186. https://doi.org/10.1021/jf020514c
10. Koyama, Y., Abe, K., Sano, Y., Shigematsu, A., & Yamada, Y. (2004). Effects of green tea on gene expression of hepatic gluconeogenic enzymes in vivo. Planta Medica, 70(11), 1100–1102. https://doi.org/10.1055/s-2004-832661
11. Burzynski, S. R. (2005). Aging: Gene silencing or gene activation? Medical Hypotheses, 64(1), 201–208. https://doi.org/10.1016/j.mehy.2004.06.019
12. Mayo Clinic Staff. (2011, October 1). Nutrition and healthy eating: Caffeine content for coffee, tea, soda and more. Mayo Clinic. Retrieved August 16, 2012, from http://www.mayoclinic.com/health/caffeine/AN01211
13. Dulloo, A. G., Seydoux, J., Girardier, L., Chantre, P., & Vandermander, J. (2000). Green tea and thermogenesis: Interactions between catechin-polyphenols, caffeine, and sympathetic activity. International Journal of Obesity & Related Metabolic Disorders, 24(2), 252–258. https://doi.org/10.1038/sj.ijo.0801110